Dana Biotech: On March 17th, margin purchase of 1.565 million yuan, margin financing balance of 4.7978 million yuan.

NightAirdropper · 2026-03-19T02:54:18+00:00

On March 17th, Dana Biotech had margin buy-ins of 156,500 yuan, repayments of 206,400 yuan, net short sales of 49,900 yuan, and a margin balance of 4,797,800 yuan, down 1.03%. There were no short selling transactions that day. Changes in margin financing and short selling balances reflect market sentiment.

NightAirdropper

2026-03-19 02:54:18

Abstract generation in progress

Securities Star News, on March 17th, Danna Biological (920009) had a margin buy of 156,500 yuan, a margin repayment of 206,400 yuan, a net margin sell of 49,900 yuan, and a margin balance of 4,797,800 yuan.

There were no securities lending transactions on that day.

The total margin and securities lending balance is 4,797,800 yuan, down 1.03% compared to yesterday.

Quick Facts

Margin trading and securities lending: An increase in margin balance reflects strengthened market bullish sentiment, while a decrease indicates a cautious or bearish market sentiment; similarly, an increase in securities lending balance reflects increased bearish sentiment, and a decrease indicates a cautious or bullish sentiment. It’s important to note that due to the financial leverage effect of margin trading and securities lending, they are a double-edged sword for investors—like a magnifying glass, profits can multiply in gains, but losses can also be amplified significantly.

The above content is compiled from public information by Securities Star, generated by AI algorithm (Wangxin Calculation Backup 310104345710301240019), and does not constitute investment advice.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.